Besides this, CDSCO has set up a five- year plan which also includes new minilabs at port offices and mobile labs with additional new manpower. With these set of measures CDSCO plans to ensure quality of drugs supplied to over 200 countries from India. With growing global requirements CDSCO had in the past started to carry out joint inspections with international regulators to monitor manufacturing plants on GMP and equip native drug inspectors with the necessary knowledge.
To take these actions seems more than necessary. Countries globally are concerned about safety and efficacy of medicines coming from India. Thus, the role of the observer in joint inspections is a step in the right direction.